HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mariacristina Siotto Selected Research

Ceruloplasmin (Ferroxidase)

1/2019Copper in Glucose Intolerance, Cognitive Decline, and Alzheimer Disease.
1/2018Prognostic Value of Serum Copper for Post-Stroke Clinical Recovery: A Pilot Study.
1/2018Serum Copper is not Altered in Frontotemporal Lobar Degeneration.
1/2018Copper dyshomeostasis in Wilson disease and Alzheimer's disease as shown by serum and urine copper indicators.
8/2017Measurements of serum non-ceruloplasmin copper by a direct fluorescent method specific to Cu(II).
1/2017Patients with Increased Non-Ceruloplasmin Copper Appear a Distinct Sub-Group of Alzheimer's Disease: A Neuroimaging Study.
1/2016Non-Ceruloplasmin Copper Distinguishes A Distinct Subtype of Alzheimer's Disease: A Study of EEG-Derived Brain Activity.
1/2016Association Between Serum Ceruloplasmin Specific Activity and Risk of Alzheimer's Disease.
10/2014Automation of o-dianisidine assay for ceruloplasmin activity analyses: usefulness of investigation in Wilson's disease and in hepatic encephalopathy.
4/2014Value of serum nonceruloplasmin copper for prediction of mild cognitive impairment conversion to Alzheimer disease.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mariacristina Siotto Research Topics

Disease

23Alzheimer Disease (Alzheimer's Disease)
01/2019 - 08/2006
6Stroke (Strokes)
05/2022 - 12/2017
4Cognitive Dysfunction
01/2019 - 04/2014
4Hepatolenticular Degeneration (Wilson's Disease)
01/2019 - 02/2014
3Neurodegenerative Diseases (Neurodegenerative Disease)
01/2019 - 11/2010
3Atrophy
01/2017 - 12/2010
2Dementia (Dementias)
01/2018 - 01/2018
2Hepatic Encephalopathy
12/2015 - 10/2014
1Pain (Aches)
05/2022
1Type 2 Diabetes Mellitus (MODY)
01/2019
1Prediabetic State (Prediabetes)
01/2019
1Relapsing-Remitting Multiple Sclerosis
01/2019
1Glucose Intolerance
01/2019
1Prodromal Symptoms
01/2018
1Brain Diseases (Brain Disorder)
01/2018
1Ischemic Stroke
01/2018
1Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar)
01/2018
1Neuralgia (Stump Neuralgia)
12/2017
1Fibrosis (Cirrhosis)
12/2015
1Movement Disorders (Movement Disorder)
06/2015
1Iron Overload
06/2015
1Parkinson Disease (Parkinson's Disease)
02/2015
1Hypercholesterolemia
04/2014
1Hypertension (High Blood Pressure)
04/2014
1Non-alcoholic Fatty Liver Disease
04/2013
1Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
02/2013
1Hemochromatosis (Bronze Diabetes)
08/2012
1Liver Diseases (Liver Disease)
08/2012
1Nervous System Diseases (Neurological Disorders)
11/2010

Drug/Important Bio-Agent (IBA)

22CopperIBA
01/2019 - 11/2010
14Ceruloplasmin (Ferroxidase)IBA
01/2019 - 12/2010
6IronIBA
01/2019 - 12/2010
5MetalsIBA
01/2018 - 11/2010
5Transferrin (beta 2 Transferrin)IBA
01/2018 - 12/2010
4Biomarkers (Surrogate Marker)IBA
05/2022 - 01/2018
3AntioxidantsIBA
05/2022 - 04/2013
3Brain-Derived Neurotrophic Factor (BDNF)IBA
11/2020 - 02/2015
3Ferritins (Ferritin)IBA
01/2018 - 04/2013
2ZincIBA
12/2018 - 01/2015
2DianisidineIBA
08/2017 - 10/2014
2Amyloid (Amyloid Fibrils)IBA
01/2017 - 01/2013
2Apolipoprotein E4IBA
01/2017 - 04/2014
2Proteins (Proteins, Gene)FDA Link
02/2014 - 04/2013
1Reactive Oxygen Species (Oxygen Radicals)IBA
05/2022
1Serotonin (5 Hydroxytryptamine)IBA
05/2021
1Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA
01/2021
1PeroxidesIBA
01/2018
1tau Proteins (tau Protein)IBA
01/2017
1IonsIBA
01/2017
1Familial apoceruloplasmin deficiencyIBA
06/2015
1Nerve Growth Factors (Neurotrophins)IBA
02/2015
1nasIBA
04/2013
1Trace Elements (Biometals)IBA
02/2013
1Apolipoproteins E (ApoE)IBA
02/2013
1Transcription Factors (Transcription Factor)IBA
01/2013
1Biological ProductsIBA
11/2010
1CurcuminIBA
11/2010
1CarbamatesIBA
08/2006
1ganstigmineIBA
08/2006
1Cholinesterase Inhibitors (Anticholinesterases)IBA
08/2006
1geneserineIBA
08/2006

Therapy/Procedure

1Physical Therapy Modalities (Physical Therapy Technique)
05/2021